Celebrate OAE’s 10th Anniversary with Cancer Drug Resistance – Enjoy a $400 APC Discount!

In 2025, OAE marks its 10th anniversary—a decade of advancing open access publishing and building a high-standard, international platform for global research exchange and innovation.

To express our gratitude for the continued trust and support of our authors, reviewers, editors, and readers, Cancer Drug Resistance (CDR) is pleased to launch the “OAE 10th Anniversary · CDR Appreciation Season” APC Discount Campaign.

We warmly invite you to submit your outstanding research on cancer drug resistance and join us in celebrating this milestone for both science and publishing.

APC Discount Details:
 · Eligibility: All manuscripts submitted to CDR during the campaign period
 · Campaign Period: September 1, 2025 (00:00 UTC) – December 31, 2025 (23:59 UTC)
 · Discount: $400 USD reduction on the Article Processing Charge (APC)
 · Standard APC: $2,800 USD
 · APC during campaign: $2,400 USD

How to Participate:
Submit your manuscript during the campaign period. The discount will be applied automatically upon acceptance—no extra steps required.

Special Early-Bird Extension:
Authors who submit during August 1–31, 2025, are also eligible for an additional benefit. By contacting the Editorial Office with your manuscript ID, you will receive a $400 APC Voucher, which can be applied to submissions to CDR made between January 1 – April 30, 2026.

Every submission drives scientific progress. The growth of CDR would not have been possible without the commitment and contributions of our global community of authors, reviewers, and editors.

We look forward to receiving your valuable research this autumn and to shaping the next decade of excellence together!

Editor: Louise Pan
Language Editor: Catherine Yang
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Cancer Drug Resistance